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The steroid receptor coactivator-3 (SRC-3), also known as AIB1, ACTR, p/CIP and NCOA3, is a transcriptional 
coactivator for nuclear receptors and certain other transcription factors. SRC-3 is widely expressed and plays 
important physiological functions and pathogenic roles in breast and prostate cancers. SRC-3 knockout (SRC-3-/-) 
mice display genetic background-dependent embryonic lethality and multiple local and systemic abnormalities. 
Since both the partial lethality and the systemic effects caused by global SRC-3 knockout interfere with down-
stream investigation of tissue-specific function of SRC-3, we have generated floxed SRC-3 (SRC-3f/f) mice with 
conditional alleles carrying loxP sites in introns 10 and 12 by a gene-targeting strategy. The two SRC-3f/f mouse 
lines (A and B) are indistinguishable from wild type mice. To test if deletion of the floxed exons 11 and 12 for 
SRC-3 nuclear receptor interaction domains and disruption of its downstream sequence for transcriptional acti-
vation domains would inactivate SRC-3 function, SRC-3f/f mice were crossbred with EIIa-Cre mice to generate 
SRC-3d/d mice with germ line deletion of the floxed SRC-3 gene. Both lines of SRC-3d/d mice exhibited growth re-
tardation and low IGF-I levels, which was similar to that observed in SRC-3-/- mice. The line A SRC-3d/d mice 
showed normal viability, while line B SRC-3d/d mice showed partial lethality similar to SRC-3-/- mice, probably 
due to variable distributions of genetic background during breeding. These results demonstrate that the floxed 
SRC-3 mouse lines have been successfully established. These mice will be useful for investigating the cell type- 
and developmental stage-specific functions of SRC-3. 
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Introduction 
The steroid receptor coactivator-3 (SRC-3), also 
known as AIB1, ACTR, p/CIP and NCOA3, is a 
member of the p160 SRC coactivator family that also 
contains SRC-1 (NCOA1) and SRC-2 (TIF2, GRIP1, 
NCOA2) (1). SRC-3 interacts with ligand-activated 
nuclear receptors such as receptors for estrogen, an-
drogen and progesterone and certain other transcrip-
tion factors such as E2F1, PEA3 and AP-1 (1-5). SRC-3 
enhances gene transcription by recruiting histone re-
modeling enzymes including CBP (cAMP response 
element-binding protein binding protein), p300 and 
p/CAF (p300 and CBP associated protein) histone 
acetyltransferases and the coactivator-associated me-
thyltransferase 1 (CARM-1) to the target gene pro-
moter (reviewed in (1)). SRC-3 has been designated as 
a proto-oncogene based on the following: SRC-3 is 
overexpressed in subgroups of human breast and 
prostate cancers (6-8); SRC-3 is required for breast and 
prostate cancer cell proliferation and survival in cul-
ture (8-10); SRC-3-deficient mice are resistant to onco-
gene- and carcinogen-induced mammary gland and 
prostate carcinogenesis and metastasis (11-14); and 
ectopic overexpression of SRC-3 in mouse mammary 
epithelial cells is sufficient to induce mammary tu-
morigenesis (15).   
 SRC-3 is expressed in brain, vascular endothelial 
and smooth muscle cells, intestinal smooth muscle 
cells, mammary gland epithelium, oocyte, prostate 
stromal and basal cells, mammary gland and prostate 
tumor cells, Sertoli cells in the testis and liver cells (16, 
17). SRC-3 knockout (SRC-3-/-) mice have been previ-Int. J. Biol. Sci. 2008, 4 
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ously generated by conventional gene-targeting 
strategies to explore the in vivo function of SRC-3 (16, 
18). Global inactivation of the SRC-3 gene in mice 
causes partial embryonic lethality depending on strain 
genetic backgrounds ((16) and unpublished data) and 
growth retardation accompanied with low IGF-I and 
IGF-binding protein 3 (IGFBP-3) levels, delays puber-
tal development, reduces female reproductive func-
tion and mammary gland growth accompanied with 
low estrogen levels (16, 18, 19), decreases estro-
gen-dependent vascular protection (20), inhibits adi-
pogenesis (21) and increases inflammatory responses 
(22). These findings indicate that SRC-3 is widely ex-
pressed, and it regulates physiological functions 
through both its cell autonomous cellular actions and 
its systemic effects on hormones such as IGF-I and 
estrogen. 
 Although  SRC-3-/- mice have provided valuable 
information regarding fundamental genetic functions 
of  SRC-3, the diverse and systemic effects of global 
SRC-3 deficiency have hindered our understanding of 
tissue- and cell type-specific and developmental 
stage-specific functions of SRC-3. In order to circum-
vent these limitations, we have generated and vali-
dated mouse lines carrying a floxed SRC-3 allele that 
is appropriate for Cre-mediated tissue-specific inacti-
vation of the SRC-3 gene. 
Materials and Methods 
DNA cloning, embryonic stem (ES) cell culture and 
gene targeting 
 The  mouse  SRC-3 genomic DNA was 
obtained from phage clones containing large 
fragments of the SRC-3 genomic DNA from the 
129SvEv mouse genome (16, 23). A 5.65-kb DNA 
fragment for the 5’ targeting arm was taken from the 
SRC-3 genomic DNA in a phage clone by Apa I and 
Sca I co-digestion and subcloned into the Pac I/Asc I 
sites of the pFRT-LoxP plasmid. A 1.9-kb SRC-3 DNA 
fragment to be floxed was taken from the same clone 
by Sca I and Mfe I co-digestion and subcloned into the 
Not I and Kpn I sites of the same plasmid. A 5-kb 
SRC-3 DNA fragment for the 3’ targeting arm was 
taken from another SRC-3 genomic DNA clone by Mfe 
I and Bmg BI co-digestion and subcloned into the Xho I 
and  Bam HI sites of the same plasmid for finishing 
construction of the targeting vector (Fig. 1). The vector 
was linearized by Xho I (inserted after the 5’ arm) di-
gestion and transfected into the TC-1 129SvEv mouse 
ES cells (24) by electroporation. Transfected ES cells 
were cultured in selection medium with G418 (Ge-
neticin) and FIAU (1-(2-deoxy-2-fluoro-beta-D-arabino 
furanosyl)-5-iodouracil) and survived clones were 
isolated for Southern blot analysis as described pre-
viously (16, 25). The 5’ probe DNA was taken from the 
SRC-3 genomic DNA clone by Sal I and Apa I diges-
tion, which was located upstream at the 5’ targeting 
arm (Fig. 1). The 3’ probe DNA was taken from the 
SRC-3 genomic DNA clone by Bmg BI and Kpn I di-
gestion, which was located downstream at the 3’ tar-
geting arm (Fig. 1). Southern blot analysis also was 
preformed with a neo probe to exclude clones with any 
random integrations of the targeting vector DNA.   
 
Fig. 1. The gene targeting strategy for generation and 
validation of the floxed SRC-3 mice. A part of the 
mouse SRC-3 gene structure is shown with indicated 
exons, restriction enzyme sites used in construction 
of the targeting vector and Southern blot analysis. 
The targeting vector structure is shown with indi-
cated regions and lengths of its 3’ and 5’ targeting 
arms. The loxP sites are indicated by triangles. The 
Frt sites are indicated by ovals. The targeted allele is 
drawn with indicated 5’ and 3’ probe positions. After 
DNA is digested with Sca I and Sal I, the 5’ probe 
should detect a 9.6-kb band for WT allele and a 
11.5-kb band for the targeted allele as indicated. 
After digested with Bam HI and Kpn I, the 3’ probe 
should detect a 6.2-kb band for the WT allele and a 
7.5-kb band for the targeted allele as indicated. The 
floxed allele can be obtained after excision of the 
Frt-flanked neo cassette through crossing to FLPeR 
transgenic mice. The P1, P2, P5 and P3 primers for 
PCR-based genotype analyses are indicated (arrow-
heads). The structure of the deleted allele obtained 
after Cre-mediated excision of the floxed region is also sketched. Int. J. Biol. Sci. 2008, 4 
 
204
Microinjection and mouse breeding 
  The correctly targeted ES clones were microin-
jected into C57/BL6 morulas to generate chemeric 
founder mice. The male chimeric mice were kept for 
breeding with female C57BL/6 mice to test germ line 
transmission of the targeted SRC-3 locus. Next, the 
male chimeric mice with proven germ line transmis-
sion ability were bred with the 129SvEv FLPeR mice 
(Stock #003946, Jackson Lab) (26) to remove the 
Frt-flanked neo expression cassette (Fig. 1). Finally, the 
FLPeR allele was excluded in incoming generations 
and the floxed SRC-3 allele was excised in germ line 
by breeding with the C57BL/6 EIIa-Cre transgenic 
mice (Stock #003724, Jackson Lab) (27). 
Mouse genotype analysis by PCR 
  The locations of PCR primers used for genotyp-
ing WT and manipulated SRC-3 alleles are indicated in 
Fig. 1. These primers include SRC3-P1 
(5’-tgacatctggtggtgtgacc), SRC3-P2 (5’-tagcccctccttttcct 
gtt), SRC3-P3 (5’-gaaacctcaaggttatccttcaatt), and 
SRC3-P5 (5’-tgctctgcttagatacctgctg). Mouse genomic 
DNA samples were prepared from tail tips by follow-
ing standard protocols. PCR reactions were performed 
using genomic DNA as templates and SRC-3 geno-
type-specific primer pairs with the following program: 
94oC, 3 minutes; 94oC, 30 seconds, 57oC 40 seconds, 
72oC, 1 minute for 35 cycles. The methods for geno-
typing EIIa-Cre and FLPeR mice were described pre-
viously (26, 27). 
Body weight and IGF-1 measurements 
 Male mice were weighed at 4, 8 and 12 weeks of 
age. Blood samples were collected from 12-week-old 
mice and serum samples were prepared and frozen at 
-80°C until analysis. Serum IGF-1 concentrations were 
measured using an ELISA kit (DSL-10-29200, Diag-
nostic Systems Lab.) by following the manufacturer’s 
instruction. Results are presented as mean ± standard 
deviation. Statistical analysis was performed using 
unpaired Student’s t test with p<0.05 to be considered 
as significant difference. 
Results 
Generation of ES cells with targeted SRC-3 allele by 
homologous recombination 
 The  mouse  SRC-3 gene spans about 79 kb in 
length and contains 23 exons, and it encodes a 160-kD 
protein with 1403 amino acid residues (23). SRC-3 
protein contains an N-terminal basic he-
lix-loop-helix/PAS (Per/ARNT/Sim) domain, a cen-
tral nuclear receptor interaction domain with multiple 
LXXLL (L, leucine, X, any amino acid residue) motifs, 
and a C-terminal transcriptional activation domain (1, 
28). To obtain a floxed SRC-3 allele appropriate for 
Cre-mediated conditional inactivation of the SRC-3 
gene, we designed and constructed a targeting vector 
that could knock in one loxP site into intron 10 and 
another loxP site into intron 12 through homologous 
recombination in mouse ES cells. The targeting vector 
contains a 5.65-kb 5’ targeting arm, a floxed 1.9-kb 
DNA fragment spanning exons 11 and 12 and intron 
11, a neo expression cassette for positive selection, a 
5-kb 3’ targeting arm and a tk expression cassette for 
negative selection (Fig. 1). The floxed exons 11 and 12 
encode the nuclear receptor interaction domain of 
SRC-3 (23, 28). In addition, the deletion of exons 11 
and 12 would also cause a coding-frame shift between 
exons 10 and 13 and result in disruption of the 
C-terminal polypeptide sequence of SRC-3 (Fig. 1).   
  After the TC-1 mouse ES cells were electropo-
rated with the targeting vector DNA and cultured in 
selection medium with G418 and FIAU, 288 survived 
clones were isolated and DNA samples were prepared 
from these clones for Southern blot screening. The 3’ 
probe detected 10 clones with a 7.5-kb targeted allele 
band in addition to a 6.2-kb wild type (WT) allele 
band after DNA samples were digested with Bam H1 
and Kpn I (Fig. 1 and Fig. 2B). Four of these positive 
clones also showed correct recombination at the 5’ lo-
cation, exhibiting a 11.5-kb targeted allele band in ad-
dition to a 9.6-kb WT allele band on Southern blot us-
ing the 5’ probe after DNA was digested with Sca I 
and Sal I (Fig. 1 and Fig. 2A). A neomycin probe was 
also used to confirm the sole homologous integration 
locus of the targeting vector at the SRC-3 gene in the 
targeted ES cells (Fig. 2C). These results demonstrate 
that multiple targeted ES clones with the floxed SRC-3 
allele had been successfully generated. Since this tar-
geted allele contains an Frt-flanked neo cassette, this 
allele is designated as SRC-3f-neo. 
 
Fig. 2. Identification of targeted ES clones by Southern blot 
analysis. A & B. Southern blot analyses of ES clones using the 
5’ and the 3’ probes. DNA was digested with Sca I and Sal I in 
panel A and with Bam HI and Kpn I in panel B. The genotypes 
of WT (+/+) and targeted (f-neo) ES clones are indicated. C. 
Southern blot analysis of ES clones using the neo probe. The Int. J. Biol. Sci. 2008, 4 
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correctly targeted clones (1A6, 1G12, 2E8 & 3E11) contain only 
one neo integration site within the 7.5-kb band for the targeted 
SRC-3 allele. DNA was digested as that in panel B.  
Generation of SRC-3
f/f mice 
  Correctly targeted ES clones were microinjected 
into C57BL/6 blastocysts to generate chimeric mice. 
Male chimeras were kept for testing germ line trans-
mission of the SRC-3f-neo allele by crossing with 
C57BL/6 female mice and by examining the coat color 
of their offspring. Agouti coat indicates a germ line 
transmission from the 129SvEv ES cell, while black 
coat indicates a C57BL/6 blastocyst donor origin. A 
total of 7 chimeric founder mice were identified to 
have germ line transmission capability. Two of these 
founder mice (lines A and B) were crossed with female 
FLPeR mice (26) to remove the Frt-flanked neo cassette 
in their pups with an SRC-3f-neo/+/FLPeR+ genotype. In 
these pups, the flippase recombinase (FLP) was ubiq-
uitously expressed and its expression resulted in exci-
sion of the Frt-flanked neo cassette in the SRC-3f-neo al-
lele. As shown in Fig. 3, PCR analyses detected WT 
and targeted alleles in FLPeR-negative  SRC-3f-neo/+ 
mice (Fig. 3A) and WT and floxed alleles in 
FLPeR-positive and neo-negative  SRC-3f/+ mice (Fig. 
3B). Subsequently, SRC-3f/+ breeding pairs were used 
to generate WT and SRC-3f/f mice that were negative 
of both neo cassette and FLPeR. Because the normal 
function of the SRC-3 gene is required for somatic 
growth and normal IGF-I levels, we measured body 
growth rates and serum IGF-I levels and found no 
differences between WT and SRC-3f/f littermates with 
a pure 129SvEv strain background (Fig. 4, A & B). 
These results indicate that the SRC-3f allele has normal 
function identical to the SRC-3+ allele. 
 
Fig. 3. Genotype analyses of mice with WT (+), targeted (f-neo), 
floxed (f) or deleted (d) SRC-3 alleles. A. Genotype analysis of 
WT and SRC-3
f-neo/+ mice. Both SRC-3
+ and SRC-3
f-neo alleles 
were detected by PCR using SRC3-P1 and SRC3-P2 primers. B. 
Genotype analysis of SRC-3
f/+ mice after the neo cassette is 
excised by crossing to FLPeR mice. Both SRC-3
+ and SRC-3
f 
alleles were detected by PCR using SRC3-P3/SRC3-P5 primers. 
Due to both loxP and Frt palindromic sequences in the floxed 
allele, the product from PCR using primers SRC3-P3 and 
SRC3-P5 produces two bands for the SRC-3
f allele and one band 
for the SRC-3
+ allele. C. Genotype analyses of mice derived 
from SRC-3
f/+ and EIIa-Cre breeding pairs. Both SRC-3
+ and 
SRC-3
f were detected by PCR using SRC3-P1 and SRC3-P2 
primers as shown in panel A. The SRC-3
d allele was detected by 
PCR using SRC3-P1 and SRC3-P3 primers. Both SRC-3
d and 
SRC-3
f alleles were detected in SRC-3
f/+/EIIa-Cre
+ mice due to 
partial excision of the floxed SRC-3 allele. D. Genotype analy-
ses of mice derived from SRC-3
f/+/EIIa-Cre
+ ( SRC-3
f-or-d/+) 
breeding pairs. PCR was performed as in panel C. From this 
breeding, mice with germ line deletion of the floxed SRC-3 
(SRC-3
d/d) were generated and identified. 
 
 
 
Fig. 4. Measurements of body weight and serum IGF-I levels. A 
& B. SRC-3
f/f and WT mice showed identical somatic growth 
patterns and similar serum IGF-I levels. The body weights of 
male WT (n=16) and SRC-3
f/f (n=20) mice with a 129SvEv strain 
background were measured at ages indicated. Blood samples 
were collected from 12-week-old male WT (n=11) and SRC-3
f/f 
(n=11) mice for IGF-I measurement. C & D. SRC-3
d/d mice 
exhibit growth retardation and low IGF-I levels. The body 
weights (Panel C) and serum IGF-I concentrations (Panel D) of 
male WT and SRC-3
d/d mice with a mixed strain background of 
C57BL/6 and 129SvEv were measured as that in Panels A & B. 
**, p < 0.005 and *, p < 0.05 by unpaired t-test. 
Germ-line deletion of the floxed SRC-3 allele reca-
pitulates an SRC-3 knockout phenotype 
  To test whether excision of the floxed region of 
the SRC-3f allele would completely inactivate the gene 
function, we crossed SRC-3f/f mice with a 129SvEv 
strain background (both A and B lines) with EIIa-Cre 
transgenic mice with a C57BL/6 strain background 
(27) and generated SRC-3f/+/EIIa-Cre+ m i c e  w i t h  a  
mixed genetic background. In these mice, the ex-Int. J. Biol. Sci. 2008, 4 
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pressed Cre resulted in a partial deletion of the SRC-3f 
allele and produced mosaic mice with both the deleted 
SRC-3 ( SRC-3d) and the remaining SRC-3f alleles in 
addition to the WT SRC-3 allele in the same mouse as 
determined by PCR genotyping using tail-tip DNA 
samples (Fig. 3C). Subsequently, SRC-3d/+ and SRC-3d/d 
mice were generated by breeding SRC-3f/+/EIIa-Cre+ 
mice and their progenies (Fig. 3D). For the A line, 25 
of WT, 57 of SRC-3d/+ and 25 of SRC-3d/d mice were ob-
tained at weaning stage from the SRC-3d/+ breeding 
pairs, which was consistent with expected Mendelian 
ratios. For the B line, 22 of WT, 33 of SRC-3d/+ and 10 of 
SRC-3d/d mice were obtained at weaning stage from the 
SRC-3d/+ breeding pairs, which was consistent with the 
partial lethal phenotype observed in SRC-3-/- mice. The 
differences between line A and line B SRC-3d/d mice in 
viability may be caused by variable distributions of 
strain background during the breeding process. 
  For both lines A and B, SRC-3d/+ mice were 
slightly smaller than age-matched WT mice (Data not 
shown). However, both male and female SRC-3d/d mice 
were significantly smaller than WT mice at all ages 
examined, including 4, 8 and 12 weeks (Fig. 4C for line 
A, and data for line B not shown). When measured at 
12 weeks of age, SRC-3d/d mice also had a remarkable 
reduction in serum IGF-I levels compared with 
age-matched WT mice (Fig. 4D for line A, and data for 
line B not shown). The growth defect and low levels of 
IGF-I phenotypes observed in SRC-3d/d mice closely 
resemble the SRC-3 knockout mice (16). These results 
demonstrate that excision of the floxed region (exons 
11 and 12) of the SRC-3f allele results in a 
loss-of-function mutant of the SRC-3 allele.   
Discussion 
  Since SRC-3 is identified as a transcriptional 
coactivator, many studies have been performed to ex-
plore its normal functions in development, metabo-
lism, reproduction and cardiovascular system, and its 
pathogenetic roles in hormonally promoted breast and 
prostate cancers (11-13, 15, 16, 18-20, 29). Because no 
germ line mutation has been found to link SRC-3 to a 
human disease, the knowledge regarding most of the 
SRC-3 in vivo functions is gained from SRC-3 knockout 
and transgenic mice. Although these mouse models 
provide valuable information, their limitations of sys-
temic effects caused by global SRC-3 deficiency have 
made it difficult to assign certain phenotypes and their 
molecular basis to a specific cell type or a specific de-
velopmental stage. In order to use the Cre-loxP system 
to inactivate SRC-3 in either a cell type-specific or a 
developmental stage-specific way, we have generated 
SRC-3f/f mice using a gene targeting strategy in this 
study.  SRC-3f/f mice exhibit normal somatic growth 
and normal IGF-I levels and are indistinguishable 
from WT mice, indicating that insertion of the loxP 
sites has no effect on the SRC-3 gene function.   
 In  SRC-3f/f mice, the paired loxP sites are located 
in introns 10 and 12. The floxed exons 11 and 12 en-
code the essential nuclear receptor interaction domain 
and the deletion of these two exons also disrupts the 
downstream coding frame. As expected, in our testing 
experiments deletion of the floxed SRC-3 alleles in 
SRC-3d/d mice caused postnatal growth retardation and 
low levels of circulating IGF-I, which are two of the 
major defects observed in SRC-3 knockout mice (1, 16, 
18). These results demonstrate that Cre-mediated exci-
sion of the floxed SRC-3 allele disrupt the function of 
the SRC-3 gene. Intriguingly, the two lines of SRC-3d/d 
mice exhibit different viability. The line A SRC-3d/d 
mice have a normal viability while the line B SRC-3d/d 
mice show a partial lethality. This discrepancy may be 
caused by uneven distributions of 129SvEv and 
C57BL/6 strain backgrounds in these two lines of 
mice during the breeding process. In agreement with 
this explanation, our recent studies have revealed that 
the lethal degrees of SRC-3-/- mice are dependent on 
strain background. Lesser, medium and severe de-
grees of lethality are found in SRC-3-/- mice with a 
129SvEv, a mixed 129SvEv/C57BL/6 and a C57BL/6 
strain background, respectively ((16) and unpublished 
results).  
  Taken together, we have generated and vali-
dated the SRC-3f/f mouse line appropriate for condi-
tional inactivation of the SRC-3 gene after crossing 
with a Cre mouse line of interest. The SRC-3f/f mouse 
line will be useful for investigating the cell type- and 
developmental stage-specific functions of SRC-3 in 
mice. 
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